Europe Digital Diabetes Management Market
Europe Digital Diabetes Management Market by Product (Device (CGM, Smart Glucometer, Insulin Patch Pump), Diabetes Apps, Service, Software & Platforms), Device Type (Handheld & Wearables), End User (Self/Home Healthcare) - Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Europe digital diabetes management market is projected to reach USD 12.53 billion by 2031 from USD 7.78 billion in 2026, at a CAGR of 10.0% during the forecast period. The rapid uptake of continuous glucose monitoring systems, smart insulin pens, and connected glucometers across Europe is a significant enabler of digital diabetes management. These devices generate continuous, real-time data that can be integrated into digital platforms for monitoring, alerts, and personalized insights.
KEY TAKEAWAYS
-
BY REGIONGermany is expected to register the highest CAGR of 11.9% during the forecast period.
-
BY PRODUCTS & SERVICESBy product & service, the devices segment dominated the market, with a share of 74.5% in 2025.
-
BY DEVICE TYPEBy device type, the wearable devices segment dominated the market, accounting for a 46.5% share in 2025.
-
BY END USERBy end user, the self/home healthcare segment is expected to be the fastest-growing segment during the forecast period.
-
COMPETITIVE LANDSCAPE - Key PlayersMedtronic (Ireland), Dexcom, Inc. (US), and Abott (US) were identified as Star players in the Europe digital diabetes management market, as they have focused on innovation and have broad industry coverage and strong operational and financial strength.
-
COMPETITIVE LANDSCAPE - Start UpsSpike (Sweden), Noom (Ukraine), and PKvitality (US) distinguished themselves among startups and SMEs due to their strong product portfolio and business strategy.
European Union initiatives promoting digital health transformation play a critical role in market growth. Programs aimed at improving interoperability, electronic health records, and cross-border health data exchange encourage the adoption of digital disease management solutions. The European Health Data Space initiative, in particular, is expected to enhance secure data access and secondary use of health data for research and innovation. These policy-level efforts enhance the digital infrastructure required for diabetes platforms to scale across countries, while supporting outcomes tracking and the generation of real-world evidence.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
There is significant evolution in the Europe digital diabetes management market driven by the increasing prevalence of diabetes and a gradual shift towards continuous, remote patient monitoring in key countries such as Germany, the UK, and France. Such priorities from healthcare providers include effective and efficient digital platforms able to deliver glycemic results at affordable public health budget costs. The rise of CGM systems, AI-based analytics, and mHealth applications resulted in their consequent influence on changing care pathways. Simultaneously, the competitive landscape is shifting due to data privacy regulations, differences in reimbursement, and integration of early hospital IT systems. At the same time, further telehealth infrastructures and value-based care models keep encouraging demand for new digital diabetes solutions.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising Prevalence of Diabetes
-
Advancements in Digital Health Technologies
Level
-
High Costs and Uneven Reimbursement
-
Data Privacy and Security Concerns
Level
-
Integration of AI and Predictive Analytics
-
Mobile Health Apps and Telehealth Expansion
Level
-
Healthcare System Fragmentation and Interoperability
-
Regulatory Complexities and Time-to-Market Delays
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising Prevalence of Diabetes
Europe has a large and growing diabetic population—estimated at over 60 million people—driven by aging demographics, rising obesity, and lifestyle shifts. This epidemiological burden is increasing demand for digital tools that help manage glucose levels, improve clinical outcomes, prevent complications, and reduce long-term healthcare costs. Higher disease prevalence motivates healthcare systems and patients alike to adopt digital diabetes solutions like CGM, data-driven apps, and connected platforms, thereby sustaining market growth across both consumer and clinical segments.
Restraint: High Costs and Uneven Reimbursement
Advanced digital diabetes management systems, especially continuous glucose monitoring (CGM) and AI-integrated platforms, carry relatively high upfront and recurring costs. While robust healthcare systems in Western Europe may cover some costs, reimbursement coverage remains inconsistent across countries, particularly in Eastern Europe. High device and platform costs can deter adoption among price-sensitive patients, constrain uptake in underfunded regions, and limit market penetration, thereby slowing growth despite strong clinical demand.
Opportunity: Integration of AI and Predictive Analytics
Artificial intelligence and machine learning are reshaping diabetes care by enabling predictive glucose trend analysis, personalized treatment recommendations, and automated decision support. AI-driven insights can optimize patient outcomes, reduce complications, and support clinicians with actionable analytics. As healthcare systems increasingly emphasize value-based care, AI offers opportunities for providers to differentiate solution offerings, increase engagement, and deliver scalable services that go beyond basic monitoring.
Challenge: Healthcare System Fragmentation and Interoperability
Europe’s diverse healthcare landscape, with varying reimbursement policies, regulatory frameworks, and EHR systems, presents interoperability challenges. The lack of standard data formats and protocols can impede the seamless integration of digital diabetes tools with existing clinical workflows, reducing efficiency and limiting the value of unified care management solutions. Addressing cross-system compatibility is critical for broader adoption.
EUROPE DIGITAL DIABETES MANAGEMENT MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Integrated digital diabetes management ecosystem combining insulin pumps, CGM systems, and data-driven software platforms, widely adopted across European hospitals and specialty clinics for intensive diabetes management | Improved glycemic control and workflow integration| Strong clinical evidence |
 |
Advanced real-time CGM solutions designed for continuous remote monitoring and smartphone-based diabetes management, increasingly used in homecare and telehealth settings across Europe | High data accuracy| Real-time insights| Enhanced patient engagement |
 |
Flash and continuous glucose monitoring systems supported by intuitive mobile apps and cloud connectivity, enabling large-scale adoption in cost-sensitive European public healthcare systems | Ease of use| Reduced finger pricks| Broad reimbursement coverage |
 |
Digital diabetes platforms integrated with blood glucose monitoring devices, offering data analytics and decision-support tools for patients and healthcare professionals in Europe | Reliable data management and clinical decision support| Strong brand trust |
 |
Connected blood glucose monitoring solutions and digital apps tailored for self-management and outpatient diabetes care across European markets | Cost-effective monitoring| Patient-friendly interfaces| Strong regional presence |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The Europe digital diabetes management market ecosystem comprises leading multinational players such as Medtronic, Abbott, Dexcom, F. Hoffmann-La Roche, and Ascensia Diabetes Care, which drive innovation across connected glucose monitoring, insulin delivery systems, and digital care platforms. These companies develop integrated solutions combining hardware, mobile applications, cloud analytics, and remote monitoring tools to support continuous diabetes management. Supporting this ecosystem are software developers, cloud service providers, sensor and semiconductor suppliers, and data analytics firms, which enable device connectivity and real-time insights. The end users include public and private hospitals, diabetes clinics, primary care providers, and home care settings across countries such as Germany, the UK, France, Italy, and Spain. This interconnected ecosystem enhances care coordination, supports value-based healthcare models, and accelerates the adoption of digital diabetes solutions across Europe.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Europe Digital Diabetes Management Market, By Product & Service
In 2025, the CGM segment held the largest market share for digital diabetes management. CGM market dominance enables players to broaden applications beyond traditional Type 1 diabetes users. By targeting insulin-dependent Type 2 diabetes patients, gestational diabetes cases, and high-risk prediabetic populations, companies can unlock new growth avenues. Strong clinical evidence, supported by large installed user bases, helps justify expanded reimbursement and physician adoption, significantly increasing patient penetration across Europe.
Europe Digital Diabetes Management Market, By Device Type
Both handheld and wearable devices are the sub-segment of the device types that are taken into account in the digital diabetes management device market. In 2025, wearable technology accounted for largest share of the market for digital diabetes management devices. During the forecast period, this segment is anticipated to grow at the highest CAGR. The market for wearables is growing as a result of technological advancements, an increase in the adoption of smart insulin pumps and insulin patches, and an increase in the number of regulatory approvals for wearables.
Europe Digital Diabetes Management Market, By End User
In 2025, the self-/home healthcare segment held the largest market share for digital diabetes management. This is primarily attributed to the rising patient acceptance of home care as a result of growing awareness of digital platforms for managing diabetes. Patients who require continuous insulin therapy benefit most from self-administration. Inpatient treatment is very expensive for patients who require long-term therapy, and it also keeps them from going back to their daily routines.
REGION
Germany to be fastest-growing region in Europe digital diabetes management market during forecast period
The German healthcare system is very well developed and integrated between primary care, specialists, and hospitals. Physicians become increasingly ready to prescribe and monitor digital diabetes solutions alongside conventional therapies. Strong clinical workflows with data standards and general acceptance of eHealth facilitate the seamless integration of digital tools that can easily and sustainably be used throughout the country in diabetes management.
EUROPE DIGITAL DIABETES MANAGEMENT MARKET: COMPANY EVALUATION MATRIX
In the Europe digital diabetes management market, Dexcom (Star) has a strong and established product portfolio and a vast geographic presence. AgaMatrix (Emerging Leader) has substantial product innovations compared to its competitors. While they have broad product portfolios, they lack a strong growth strategy for business development, particularly in terms of geographic expansion, strategic partnerships, and aggressive commercialization initiatives compared to leading players in the market.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- Medtronic (Ireland)
- Dexcom, Inc. (US)
- Abbott (US)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Ascensia Diabetes Care Holdings AG (Switzerland)
- Insulet Corporation (US)
- Tandem Diabetes Care (US)
- B. Braun Melsungen AG (Germany)
- LifeScan, Inc. (US)
- Tidepool (US)
- AgaMatrix (US)
- Glooko, Inc. (US)
- DarioHealth Corporation (Israel)
- One Drop (US)
- Dottili (Finland)
- Ypsomed Holding AG (Switzerland)
- ARKRAY (Japan)
- ACON Laboratories, Inc. (US)
- Care Innovations, LLC (US)
- Health2Sync (Taiwan)
- Emperra GmbH E-Health Technologies (Germany)
- Azumio (US)
- Decide Clinical Software GmbH (Austria)
- Pendiq GmbH (Germany)
- BeatO (India)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size Value in 2026 (Value) | USD 7.78 BN |
| Revenue Forecast in 2031 (Value) | USD 12.53 BN |
| Growth Rate | 10.00% |
| Years Considered | 2024–2031 |
| Base Year | 2025 |
| Forecast Period | 2026–2031 |
| Units Considered | Value (USD MN/BN), Volume (Thousand Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered | By Product & Service: Devices, Apps, Data Management Software & Platforms and Services, By Device Type: Wearable Devices, Handheld Devices, By End User: Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Academic & Research Institutes |
| Country Covered | Germany, France, UK, Italy, Spain, and Rest of Europe |
WHAT IS IN IT FOR YOU: EUROPE DIGITAL DIABETES MANAGEMENT MARKET REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Product Analysis | Comparative analysis of digital diabetes solutions including CGM systems, connected blood glucose meters, insulin pumps, mobile health apps, and AI-enabled data platforms, with assessment of standalone vs integrated ecosystems across Europe | Evaluation of data accuracy, interoperability, user experience, clinical decision support, and real-world outcome impact to support optimized diabetes care pathways in European healthcare systems |
| Company Information | Detailed profiles of leading global and European digital diabetes players covering product portfolios, software capabilities, regulatory approvals, reimbursement status, partnerships, and recent developments across key European countries | Competitive benchmarking of players based on technology maturity, reimbursement access, ecosystem strength, and innovation focus, enabling strategic positioning and partner selection |
| Geographic Analysis | In-depth regional assessment of the Europe digital diabetes management market covering Germany, the UK, France, Italy, Spain, Nordics, and other key markets | Country-level market sizing, CAGR forecasts, reimbursement landscape analysis, digital adoption trends, and policy impact assessment to guide market entry and expansion strategies |
RECENT DEVELOPMENTS
- April 2022 : Dexcom launched Dexcom ONE device worldwide.
- October 2022 : Abbott Laboratories launched the Freestyle Libre 3 CGM device worldwide.
- October 2021 : LifeScan, Inc. (US) launched OneTouch Solutions. This is a holistic digital health offering linking people with diabetes to solutions and support from proven experts.
- September 2020 : Roche Diagnostics (Switzerland) launched a remote patient monitoring solution, which is a new element of the RocheDiabetes Care Platform and uses its pattern detection feature.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The study involved four major activities in estimating the current size of the Europe Digital Diabetes Management Market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
Secondary sources referred to for this research study include financial statements of companies offering Digital Diabetes Management and information from various trade, business, and professional associations. The secondary data was collected and analyzed to arrive at the overall size of the Europe Digital Diabetes Management Market, which was validated by primary respondents.
Primary Research
Extensive primary research was conducted after obtaining information regarding the Europe Digital Diabetes Management Market scenario through secondary research. Several primary interviews were conducted with market experts from both, the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interview. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors, from business development, marketing, product development/innovation teams, and related key executives from Digital Diabetes Management manufacturers; distributors; and key opinion leaders.
Primary interviews were conducted to gather insights such as market statistics, data of revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side, customer/end users who are using Digital Diabetes Management were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage of Digital Diabetes Management and future outlook of their business which will affect the overall market.
Market Size Estimation
The research methodology used to estimate the size of the Europe Digital Diabetes Management Market includes the following details.
The market sizing of the market was undertaken from the global side.
Country level Analysis: The size of the Europe Digital Diabetes Management Market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products and services in the overall Europe Digital Diabetes Management Market was obtained from secondary data and validated by primary participants to arrive at the total Europe Digital Diabetes Management Market. Primary participants further validated the numbers.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Europe Digital Diabetes Management Market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Data Triangulation
After arriving at the overall size from the market size estimation process explained above, the total market was split into several segments and subsegments. The data triangulation and market breakdown procedures explained below were implemented, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics for various market segments and subsegments. The data was triangulated by studying various factors and trends from the demand and supply sides. Along with this, the market size was validated using both the top-down and bottom-up approaches.
Market Definition
Digital diabetes management refers to electronic medical solutions used for remote monitoring, analysis and management of patients with diabetes. Diabetes is a metabolic disorder that leads to elevated blood sugar levels in the body. Digital diabetes management involves the use of software-based applications, platforms and devices, such as smart glucose meters, insulin pens, sensors, closed-loop systems and insulin patches.
These systems are used to manage blood glucose, pressure and cholesterol levels and effectively track and maintain the record of the patients. They also aid in improving healthcare processes, delay or prevent diabetes complications and minimize medical costs for the patients. As a result, they are widely used across at-home and self-care facilities, hospitals, clinics and research institutes.
Key Stakeholders
- Senior Management
- End Users
- Diabetes Care Providers
- Finance/Procurement Department
Report Objectives
- To define, describe, analyze, and forecast the Europe Digital Diabetes Management Market by product, type, end user, and region
- To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the Europe Digital Diabetes Management Market in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To strategically profile key players in the global Europe Digital Diabetes Management Market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as product launches, expansions, acquisitions, partnerships, agreements, and other developments of leading players in the global Europe Digital Diabetes Management Market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Geographic Analysis
- Further breakdown of the Rest of Europe Digital Diabetes Management Market into the Netherlands, Austria, Belgium, and others
- Further breakdown of the Rest of Asia Pacific Europe Digital Diabetes Management Market into Singapore, Malaysia, and others
Company Information
- Detailed analysis and profiling of additional market players
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Europe Digital Diabetes Management Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free Customisation
Growth opportunities and latent adjacency in Europe Digital Diabetes Management Market